Neuren Pharmaceuticals Limited (ASX:NEU)

Neuren Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	3.15	17.09	40.18	36.78	24.19
Short-Term Investments	219.09	211.45	-	-	-
Cash & Short-Term Investments	222.24	228.54	40.18	36.78	24.19
Cash Growth	-2.76%	468.79%	9.23%	52.07%	74.72%
Accounts Receivable	172.91	12.8	-	0.01	-
Other Receivables	2.42	1.61	1.09	1.42	0.76
Receivables	175.33	14.41	1.09	1.42	0.76
Prepaid Expenses	0.4	4.21	1.98	1.84	-
Other Current Assets	1.36	-	-	-	-
Total Current Assets	399.33	247.16	43.25	40.04	24.94
Property, Plant & Equipment	0.03	0.04	0.02	0.01	0.01
Long-Term Deferred Tax Assets	10.35	0.77	-	-	-
Total Assets	409.71	247.97	43.27	40.06	24.95
Accounts Payable	1.45	0.68	0.26	0.25	0.17
Accrued Expenses	1.45	2.74	0.72	0.56	0.59
Current Income Taxes Payable	42.87	37.12	-	-	-
Other Current Liabilities	-	2.23	0.7	-	-
Total Current Liabilities	45.76	42.76	1.68	0.8	0.75
Total Liabilities	45.8	42.76	1.68	0.8	0.75
Common Stock	165.27	173.13	167.74	167.58	145.57
Retained Earnings	180.43	38.39	-118.69	-118.88	-111.08
Comprehensive Income & Other	18.2	-6.31	-7.46	-9.45	-10.28
Total Common Equity	363.9	205.21	41.59	39.25	24.2
Shareholders' Equity	363.9	205.21	41.59	39.25	24.2
Total Liabilities & Equity	409.71	247.97	43.27	40.06	24.95
Net Cash (Debt)	222.24	228.54	40.18	36.78	24.19
Net Cash Growth	-2.76%	468.79%	9.23%	52.07%	74.72%
Net Cash Per Share	1.70	1.75	0.31	0.31	0.23
Filing Date Shares Outstanding	127.01	127.27	125.97	125.97	114.61
Total Common Shares Outstanding	127.01	127.27	125.97	125.97	114.61
Working Capital	353.57	204.39	41.57	39.24	24.19
Book Value Per Share	2.87	1.61	0.33	0.31	0.21
Tangible Book Value	363.9	205.21	41.59	39.25	24.2
Tangible Book Value Per Share	2.87	1.61	0.33	0.31	0.21

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.